Meet the ECRN Committee

Meet the ECRN Committee


Steven Fagan (RCSI)

Steven Fagan is a postdoc in the Royal College of Surgeons in Ireland. He investigating the role of non-coding RNA in neuronal and astroglial function with specific attention to tRNA fragments in epilepsy. In his spare time Steven enjoys hiking, cycling and camping, and after that cooking up a feast.







Oisín C. Joyce (TCD)

Oisín C. Joyce is a second-year PhD student in Trinity College Dublin. The current focus of Oisín’s research is to determine how concussion and traumatic brain injury in current and retired sporting athletes can affect brain health using a measure of multisensory integration and whether there is an associative link to cardiovascular health and disease. Outside of the lab, although it defies his research goals, he loves to box. He also likes to read and collect comic books which he feel aids in his passion and creativity for neuroscience and research.




 Erin Harris (UCC)

Erin Harris is a postdoctoral researcher in the Department of Anatomy & Neuroscience at University College Cork. She studies sex differences in stress-related psychiatric illness using a rat model. Originally from the United States, Erin has been living in Cork for 3 years. Outside of the lab, she enjoys singing, making silly TikToks, and exploring Ireland.






Janosch Heller (DCU)

Janosch Heller is an Assistant Professor in Biomedical Sciences at Dublin City University. Janosch’s lab is interested in how astrocytes change in diseases such as epilepsy and how these cells can be targeted as novel treatment options. In his free time, Janosch likes to explore the Irish countryside, to cook and bake, and to indulge in the Real Housewives franchise.





Aoife Cosgrave (UCD)

Aoife Cosgrave is a 3rd year PhD student from University College Dublin and she is exploring the anti-inflammatory and neuroprotective properties of lesser-explored phytocannabinoids in models of acute neuroinflammation. To get a break from the lab, Aoife likes to read and paint and recently went back playing Gaelic football (she hadn’t picked up a football since she was a teenager) after playing tag rugby for a few years!







Caoimhe Tyndall (TCD)

Caoimhe Tyndall is a second-year PhD student in Trinity College Dublin, researching mechanisms by which alpha-synuclein induces neuroinflammation and neurodegeneration in Parkinson’s Disease. When Caoimhe is not in the lab, she in the sea – sailing, surfing, and sea swimming are her go to outdoor activities. When on land, musical theatre is her buzz.






FENS Forum 2022: submit your symposium and technical workshop proposals!

FENS Forum 2022: submit your symposium and technical workshop proposals!
The call for symposia and technical workshops for the FENS Forum 2022 is open!
Don’t miss this opportunity to share your research and shape the scientific programme of Europe’s premier neuroscience meeting: with 56 symposia across four days, there is enormous scope to showcase your field!
Full list of themes and submission at:
Discover some of the reasons why you should submit a proposal:

Huntington’s Disease Awareness Campaign: UK & Ireland wide

Huntington’s Disease Awareness Campaign: UK & Ireland wide

Some of you will know the reality of living with Huntington’s while others have never encountered the condition which affects thousands of people across the UK & Ireland. 

#FamilyMatters is a small charity and group of advocates for families living with #HuntingtonsDisease. Learn more by exploring their Living History wall, make a contribution, watch and read contributor stories, or find out more about Huntington’s disease at  




PD-MitoQUANT publishes January 2021 newsletter

PD-MitoQUANT publishes January 2021 newsletter

The latest version of the PD-MitoQUANT newsletter was published on January 27, 2021. In it, partners share stories from the Parkinson’s UK Virtual Research Conference. Meet Dr Alexander Kel, Founder and Chief Scientific Officer (CSO) of geneXplain GmbH. And much more! Visit

Learn more about the project on the PD-MitoQUANT website.

This project has received funding from the Innovative Medicines Initiative 2 Joint Undertaking under grant agreement No 821522. This Joint Undertaking receives support from the European Union’s Horizon 2020 research and innovation programme and EFPIA and Parkinson’s UK.

The material presented and views expressed here reflect the author’s view and neither IMI nor the European Union, EFPIA, or any Associated Partners are responsible for any use that may be made of the information contained herein.